| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |